Bio-Techne (TECH) Revenue (2009 - 2026)

Bio-Techne has reported Revenue for 18 years, with the latest figure at $311.4 million in Q1 2026.

• For the quarter ending Q1 2026, Revenue fell 1.51% year-over-year to $311.4 million; the trailing twelve-month figure through Mar 2026 stood at $1.2 billion (changed 0.17% YoY), and the FY2025 full-year result was $1.2 billion, up 5.23% from the prior year.
• Revenue for Q1 2026 stood at $311.4 million, up from $295.9 million in the prior quarter.
• The five-year high for Revenue was $317.0 million in Q2 2025, with the low at $2.0 million in Q3 2022.
• Average Revenue over 5 years is $277.7 million, with a median of $294.1 million recorded in 2023.
• Year-over-year, Revenue tumbled 99.22% in 2022 and surged 13746.75% in 2023.
• Tracing TECH's Revenue over 5 years: stood at $271.6 million in 2022, then rose by 0.37% to $272.6 million in 2023, then climbed by 8.96% to $297.0 million in 2024, then decreased by 0.39% to $295.9 million in 2025, then gained by 5.25% to $311.4 million in 2026.
• The last three Revenue figures came in at $311.4 million (Q1 2026), $295.9 million (Q4 2025), and $286.6 million (Q3 2025), per Business Quant data.

Peer Comparison